Last update 01 Nov 2024
SZEY-2108
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with SZEY-2108A Randomized, Double-blind, Placebo-controlled Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of SZEY-2108 Administreated as Single and Repeated Intravenous Doses in Chinese Healthy Subjects
评价注射用SZEY-2108在中国健康成年受试者中随机、双盲、安慰剂对照、单剂和多剂递增静脉输注给药的安全性、耐受性及药代动力学特征的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of SZEY-2108 for injection in healthy Chinese adult subjects using a randomized, double-blind, placebo-controlled, single-dose and multiple-dose ascending intravenous infusion
100 Clinical Results associated with SZEY-2108
Login to view more data
100 Translational Medicine associated with SZEY-2108
Login to view more data
100 Patents (Medical) associated with SZEY-2108
Login to view more data
100 Deals associated with SZEY-2108
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Carbapenem Resistant Bacterial Infection | Phase 1 | CN | 05 Sep 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free